Table 2.
Twelve-month prevalence estimates of chronic physical conditions and mental conditions separately in WMH surveys in developing and developed countries
| Developing countries | Developed countries | All countries | ||||
|---|---|---|---|---|---|---|
| % | (SE) | % | (SE) | % | (SE) | |
| I. Chronic physical conditions | 47.1 | (0.8) | 56.1 | (0.6) | 52.9 | (0.5) |
| Arthritis | 11.5 | (0.4) | 15.6 | (0.4) | 14.2 | (0.3) |
| Cancer | 0.5 | (0.1) | 3.2 | (0.2) | 2.2 | (0.1) |
| Cardiovascular disorders | 14.3 | (0.5) | 18.9 | (0.3) | 17.3 | (0.3) |
| Chronic pain conditions | 22.5 | (0.6) | 22.7 | (0.4) | 22.6 | (0.3) |
| Diabetes | 2.7 | (0.2) | 5.3 | (0.2) | 4.3 | (0.1) |
| Digestive disorders | 5.0 | (0.3) | 2.7 | (0.1) | 3.5 | (0.1) |
| Headaches or migraines | 14.5 | (0.5) | 11.4 | (0.3) | 12.5 | (0.3) |
| Insomnia | 3.2 | (0.2) | 5.1 | (0.2) | 4.4 | (0.2) |
| Neurological disorders | 1.0 | (0.1) | 1.1 | (0.1) | 1.0 | (0.1) |
| Respiratory disorders | 12.0 | (0.5) | 19.8 | (0.5) | 17.1 | (0.4) |
| II. Mental conditions | 12.7 | (0.4) | 15.1 | (0.4) | 14.2 | (0.3) |
| Alcohol abuse | 2.4 | (0.2) | 1.5 | (0.1) | 1.8 | (0.1) |
| Bipolar disordera | 1.0 | (0.1) | 2.1 | (0.2) | 1.6 | (0.1) |
| Drug abuseb | 0.3 | (0.1) | 0.8 | (0.1) | 0.6 | (0.1) |
| Generalized anxiety disorder | 0.5 | (0.1) | 1.6 | (0.1) | 1.2 | (0.1) |
| Major depressive episode | 4.9 | (0.2) | 6.4 | (0.2) | 5.8 | (0.1) |
| Panic disorder | 1.2 | (0.1) | 1.8 | (0.1) | 1.6 | (0.1) |
| Post-traumatic stress disorder | 0.8 | (0.1) | 1.7 | (0.1) | 1.4 | (0.1) |
| Social phobiac | 1.5 | (0.1) | 3.5 | (0.2) | 2.7 | (0.1) |
| Specific phobiad | 5.4 | (0.3) | 6.6 | (0.3) | 6.2 | (0.2) |
| III. Any condition | 52.0 | (0.8) | 60.3 | (0.6) | 57.3 | (0.5) |
| (n) | (10,836) | (20,231) | (31,067) | |||
a
Bipolar disorder was not assessed in Belgium, France, Germany, Israel, Italy, the Netherlands, Nigeria, Spain and Ukraine
b
DrugAbuse was not assessed in Belgium, France, Germany, Italy, Netherlands and Spain.
c
Social Phobia was not assessed in Israel.
d
Specific Phobia was not assessed in Israel and Ukraine.